Laurion Capital Management LP Verastem, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.02 - $1.83 $65,218 - $117,010	63,940 New	63,940 $74,000
Q2 2018 Aug 13, 2018	SELL	$2.88 - $8.67 $190,704 - $574,101	-66,217 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$2.92 - $3.81 $1.51 Million - $1.97 Million	-517,036 Reduced 88.65%	66,217 $197,000
Q4 2017 Feb 13, 2018	BUY	$2.99 - $4.85 $1.74 Million - $2.83 Million	583,253	583,253 $1.79 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.